FDA Commissioner Marty Makary resigns as Biogen unveils new Alzheimer’s data
read at Endpoints ↗RegulatoryNeutral
Marty Makary announced his resignation from the role of FDA commissioner, ending his tenure amid recent political developments.
Biogen disclosed fresh data from its Alzheimer’s disease program, adding to the ongoing discussion of therapeutic progress in the field.
The combined announcements underscore a shift in regulatory leadership while highlighting continued research activity in neuro‑degenerative diseases, topics of interest to pharma professionals and investors.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Makary resigns; Biogen reports Alzheimer’s data; and more”
read at Endpoints ↗83 words · retrieved May 16
comments(0)
5-min edit window · permanent after that